About Me.

Hello.

Thank you for being interested in my experience to see if I'll be a good support for you.

 

Education

In progress. Doctor of Philosophy (Matrescence), La Trobe University, Melbourne.

2017. Doctor of Philosophy (Prescription medicine misuse), University of Sydney, Sydney.

2010. Masters in Criminology, University of Sydney, Sydney.

2008. Bachelor of Liberal Studies/Psychology (Hons), University of Sydney, Sydney.

2006. Certificate IV Telephone Counselling, Lifeline, Sydney.

Certificates / Diplomas

2025. Certificate IV Breastfeeding Counselling and Education, Australian Breastfeeding Association, Melbourne.

2025. Conscious Hypnosis Practitioner, The Life Coaching College, Melbourne. 

In Progress. Master Practitioner Coach, The Life Coaching College, Melbourne.

​

​​

Research Experience.

8 years - various Universities (University of Sydney, Monash University, University of New South Wales)

5 years - The Black Dog Institute.

4 years - NSW Health

2 years - health start-ups

1 year - Bureau of Crime Statistics and Research.

​

Lived Experience.

Motherhood. Girl mum. Boy mum.

Pregnancy. Pubic pain.

Birth. Two c-sections.

Breastfeeding. Mixed Feeding. Formula Feeding. Nipple Shield. Pumping Hand Expressing. Medication.

Breastfeeding grief.

Postpartum anxiety.

Child food allergies / intolerance (eggs and dairy).

Returning to work.

Enrolling child in daycare.

​

Founder

2020. The Authentic Research Experience

2024. Mumming

​

Writing

The Yummy Mummy Pageant (unpublished novel)​

I'm not broken (personal story; submitted for review)

​

30 Journal Articles (reverse chronological order).

*Zhu L, Hayen A, Blanch B, Engstrom N, Doust JA, Semsarian C and Bell KJL (2024). First implantable cardiac defibrillator insertions in New South Wales, 2005–2020: an analysis of linked administrative data. Medical Journal of Australia; 220 (5): 249-257.

*Barratt Ross S, Jones K, ​Blanch B​, Puranik R, McGeechan K, Barratt A, Semsarian C (2020). A systematic review and meta-analysis of the prevalence of left ventricular non-compaction in adults; ​European Heart Journal;​ 41(14):1428-1436.

*Gisev N, Pearson S, B, Larance B, Larney S, ​Blanch B,​ Degenhardt L (2019). A population-based study of transdermal fentanyl initiation in Australian clinical practice. European Journal of Clinical Pharmacology;​ 75(3): 401-408.

*Blanch B​, Lago LP, Sy R, Harris PJ, Semsarian C, Ingles J (2018). Implantable cardioverter-defibrillator therapy in Australia, 2002-2015. ​Medical Journal of Australia; 209(3): 123-129.

*Blanch B​, Sweeting J, Semsarian C, Ingles J (2017). Routinely collected health data to study inherited heart disease: a systematic review (2000-2017). ​Open Heart;​ 4: e000686.

*Blanch B​, Degenhardt L, Buckley NA, Gisev N, Dobbins TA, Karanges EA, Larance B, Larney S, Pearson S (2017). Prescription opioid access and factors associated with increasing number of prescribers, pharmacies and dispensings: an observational study using pharmaceutical claims. ​Pain Medicine; 1​ 9(6): 1170-1183.

*Karanges EA, Buckley NA, Brett J, ​Blanch B,​ Litchfield M, Degenhardt L, Pearson S (2017). Trends in opioid utilisation in Australia, 2006-2015: additional insights from multiple metrics. ​Pharmacoepidemiology & Drug Safety​;​ 2​ 7(5): 504-512.

*Gisev N, Pearson S, Karanges EA, Larance B, Buckley NA, Larney S, Dobbins T, ​Blanch B, Degenhardt L (2017). To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia? ​Pharmacoepidemiology and Drug Safety;​ 27(5): 550-555.

*Gisev N, Pearson S, ​Blanch B​, Larance B, Dobbins T, Larney S, Degenhardt L (2016). Initiation of strong prescription opioid analgesics in Australia: cohort characteristics and factors associated with the type of opioid analgesic initiated. ​British Journal of Clinical Pharmacology;​ 82: 1123-1133.

*Karanges E, ​Blanch B,​ Buckley N, Pearson S (2016). Twenty-five years of prescription opioid use in Australia: a whole-of-population analysis using pharmaceutical claims. British Journal of Clinical Pharmacology​; 82: 255-267.

*Blanch B​, Daniels B, Litchfield M, Pearson SA (2015). Looking forward and looking back: the balancing act in new drug user designs for          pharmacoepidemiological research. Pharmacoepidemiology and Drug Safety;​ 24: 1117-1119.

*Blanch B,​ Buckley N, Mellish L, Dawson A, Haber P, Pearson SA (2015). Harmonizing post-market surveillance of prescription drug misuse: a systematic review of observational studies using routinely collected data (2000-2013). ​Drug Safety​; 38: 553-564.

*Degenhardt L, ​Blanch B,​ Gisev N, Larance B, Pearson SA (2015). The POPPY Research Programme protocol: investigating opioid utilisation, costs and patterns of extramedical use in Australia. ​BMJ Open; ​5: e007030.

*Mellish L, Karanges E, Litchfield M, Schaffer A, ​Blanch B​, Daniels B, Seagrave A, Pearson SA (2015). The Australian Pharmaceutical Benefits Scheme data collection: a practical guide for researchers. ​BMC Research Notes; ​8: 634.

*Blanch B,​ Pearson SA, Haber PS (2014). An overview of the patterns of prescription opioid use, costs and related harms in Australia. ​British Journal of Clinical Pharmacology;​ 78: 1159-1166.

*Langton JM, ​Blanch B,​ Drew AK, Haas M, Ingham JM, Pearson SA (2014). Retrospective studies of end-of-life resource utilization and costs in cancer care using health administrative data: A systematic review. ​Palliative Medicine; ​28: 1167-1196.

*Gilfillan D, Parker G, Sheppard E, Manicavasagar V, Paterson A, ​Blanch B​, McCraw S (2014). Is cognitive behaviour therapy of benefit for melancholic depression? Comprehensive Psychiatry; 5​ 5: 856-860.

*Langton JM, ​Blanch B​, Pesa N, Park JM, Pearson SA (2013). How do medical doctors use a web-based oncology protocol system? A comparison of Australian doctors at different levels of medical training using logfile analysis and an online survey. ​BMC Medical Informatics and Decision Making; 1​ 3: 82.

*Parker G, ​Blanch B​, Paterson A, Hadzi-Pavlovic D, Sheppard E, Manicavasagar V, Synnott H, Graham R, Friend P, Gilfillan D, Perich T (2013). The superiority of antidepressant medication to cognitive behaviour therapy in melancholic depressed patients: a 12-week single-blind randomized study. ​Acta Psychiatrica Scandinavica; ​128: 271-281.

*Parker G, Fletcher K, ​Blanch B​, Greenfield L (2013). The ‘real world’ utility of a web based bipolar screening measure. ​Acta Psychiatrica Scandinavica; ​127: 373-380.

*Parker G, Paterson A, ​Blanch B​ (2013). Suggested early onset of true action of antidepressant drugs may be artefactual - a heuristic study. ​International Clinical Psychopharmacology; 2​ 8: 29-32.

*Parker G, McCraw S, ​Blanch B​, Hadzi-Pavlovic D, Synnott H, Rees AM (2013). Discriminating melancholic and non-melancholic depression by prototypic clinical features. ​Journal of Affective Disorders; ​144: 199-207.

*Wagland P, ​Blanch B​, Moore E (2013). Participant satisfaction with youth justice conferencing. ​Crime and Justice Bulletin; ​170.

*Wagland P, ​Blanch B ​(2013). Youths in custody in NSW: future expectations and aspirations. ​Crime and Justice Bulletin; 1​ 73.

*Parker G, Paterson A, Fletcher K, ​Blanch B​, Graham R (2012). The ‘magic button question’ for those with a mood disorder – would they wish to re-live their condition?​ Journal of Affective Disorders;​ 136: 419-424.

*Parker G, Fletcher K, ​Blanch B​, Greenfield L (2012). Take up and profile of individuals accessing a web-based bipolar self-test screening measure. ​Journal of Affective Disorders;​ 138: 117-122.

*Parker G, Paterson A, Fletcher K, Hyett M, ​Blanch B​ (2012). Out of the darkness: the impact of a mood disorder over time. ​Australasian Psychiatry; 2​ 0: 487-491.

*Parker G, ​Blanch B​, Crawford J (2011). Does gender influence response to differing psychotherapies by those with unipolar depression? ​Journal of Affective Disorders;​ 130: 17-20.

*Parker G, Fletcher K, Barrett M, Synnott H, Breakspear M, Rees A, ​Blanch B​ (2011). The impact of detecting bipolar disorder in previously diagnosed unipolar patients at a specialist ‘Depression’ Clinic.​ Journal of Nervous and Mental Disease​; 199: 419-422.

*Parker G, ​Blanch B​, Fletcher K, Greenfield L (2011). Evaluating the utility of a bipolar self-test screening measure. ​Australasian Psychiatry;​ 19: 317-320.